Table 1.
Antigen-binding domains tested as CAR elements in this study.
Antibody Name | Type | Target | Affinity (K D) | Cross-Reactivity | Competition | Epitope Location | Ref |
---|---|---|---|---|---|---|---|
sdAb021 | sdAb | EGFR (Erbb1) | 38.5 nM | Human, Cyno | Competitive with sdAb027, partial with sdAb028 | Unknown, likely domain IV | (29) |
sdAb027 | sdAb | EGFR (Erbb1) | 1.6 nM | Human, Cyno | Competitive with sdAb021, partial with sdAb028 | Unknown, likely domain IV | (29) |
sdAb028 | sdAb | EGFR (Erbb1) | 9.0 nM | Human, Mouse | Partial competition with sdAb021 and sdAb027 | Unknown, likely domain IV | (29) |
Trastuzumab | scFv | HER2 (Erbb2) | n.d. (5 nM) a | Human, Cyno | Juxtamembrane conformational epitope in domain IV | Very membrane proximal | (30, 31) |
F265 | scFv | EGFRvIII | n.d. (27.5 nM) a | Unknown | Domain I/III neoepitope, non-competitive with F269 | Membrane distal | (32) and unpublished |
F269 | scFv | EGFRvIII | n.d. (31.5 nM) a | Unknown | Domain I/III neoepitope of EGFR, non-competitive with F265 | Membrane distal | (32) and unpublished |
Binding of scFvs was not evaluated. Monovalent affinity of full-length IgG is shown in parentheses.
Cyno, cynomolgus monkey.